Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,419 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders

NCT03048344

Conditions
Advanced Hematological Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Weill Cornell Medical College New York, United States
  • Vanderbilt University Nashville, Tennessee, United States
  • MD Anderson Houston, Texas, United States
View Trial Details
Completed

An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

NCT02472145

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Orange, California, United States
  • Aurora, Colorado, United States
  • New Orleans, Louisiana, United States
  • Detroit, Michigan, United States
View all 81 locations
View Trial Details
Completed

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

NCT01031368

Conditions
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +31 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia

NCT02016729

Conditions
Acute Myeloid Leukemia, Advanced Malignancy, Cancer, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Buffalo, New York, United States
  • Research Site Charlotte, North Carolina, United States
  • Research Site Salt Lake City, Utah, United States
View Trial Details

Related conditions